News

A small startup on a moshav has come up with a way to immunize plants to make them genetically resistant to disease. The U.S. government found the technology so promising that it's helping to fund pre-field trial tests.

Dr Martin Trick and Dr Cristobal Uauy have recently published a new study that applies next generation sequencing techniques to wheat and shows how it can aid in fine mapping genes to the level needed by the plant breeding community more quickly and efficiently than has been possible before.

IDT sponsors undergraduate iGEM teams for the second year running.

H3 Biomedicine to employ Horizon’s unique gene editing technology and isogenic cell lines to validate genetically defined drug targets for development of cancer therapeutics.

European funding for cancer research has led to some interesting results in recent years, says Carl-Johan Ivarsson, CEO at Qlucore.

Quantitative PCR expert adds ZyGEM DNA and RNA extraction kits to its select product offerings.

Dr. Yusuf Zafar from Pakistan and Dr. Andrew Paterson from the USA win the awards. Dr. Paterson is a speaker at the upcoming meeting on Agri-Genomics in Frankfurt, Germany in September 4-5, 2012

UMass chemical engineers and collaborators discover a high-yield method for producing plastic bottles from biomass.

Schafer brings deep experience in research, “big pharma” management and building new businesses.

Scientists have shown that a brand new type of cancer pill that exploits the emerging field of epigenetics is safe for human use, according to a Phase I trial reported today in Clinical Cancer Research.